Admission Date:  [**2117-3-4**]              Discharge Date:   [**2117-3-10**]  Date of Birth:  [**2053-12-5**]             Sex:   M  Service: MEDICINE  Allergies: Penicillins / Aspirin / Codeine  Attending:[**First Name3 (LF) 1990**] Chief Complaint: abdominal pain, fever  Major Surgical or Invasive Procedure: ERCP [**3-5**] at OSH:  percutaneous biliary tube placement, cholecystectomy, Rt sided AKA  History of Present Illness: 63M with PVD, EtOH and cocaine abuse, admitted to [**Hospital **] Hospital on [**2117-2-22**] with septic shock and E.coli bacteremia, now transferred to [**Hospital1 18**] for further workup and potential ERCP.
He was intubated and required both vasopressin and norepinephrine.
He had perc CCY tube placed on [**2-24**].
There was also concern for worsening RLE ischemia on pressors vs. true graft thrombosis.
Has baseline facial asymmetry since MVA.
Past Medical History: - Severe PVD s/p multiple bypass surgeries of LEs (L femoral to above knee bypass [**2115**], R external iliac to superficial femoral artery bypass [**2115**] and R common iliac to above knee [**Doctor Last Name **] bypass [**2116**]) and carotids (L CEA [**2115**]).
RUQ port incision had been draining small amount serous fluid, no purulence or bleeding.
2+ L DP and PT pulses.
Pertinent Results: [**2117-3-4**] 09:18PM   GLUCOSE-96 UREA N-20 CREAT-0.5 SODIUM-138 POTASSIUM-4.1 CHLORIDE-106 TOTAL CO2-22 ANION GAP-14 [**2117-3-4**] 09:18PM   estGFR-Using this [**2117-3-4**] 09:18PM   ALT(SGPT)-192* AST(SGOT)-92* LD(LDH)-211 CK(CPK)-130 ALK PHOS-263* AMYLASE-516* TOT BILI-0.7 [**2117-3-4**] 09:18PM   LIPASE-241* [**2117-3-4**] 09:18PM   CK-MB-2 cTropnT-0.16* [**2117-3-4**] 09:18PM   IRON-65 [**2117-3-4**] 09:18PM   ALBUMIN-3.4* CALCIUM-8.9 PHOSPHATE-4.1 MAGNESIUM-2.0 [**2117-3-4**] 09:18PM   calTIBC-313 FERRITIN-314 TRF-241 [**2117-3-4**] 09:18PM   VIT B12-GREATER TH FOLATE-15.8 [**2117-3-4**] 09:18PM   TRIGLYCER-131 [**2117-3-4**] 09:18PM   TSH-1.7 [**2117-3-4**] 09:18PM   HBsAg-NEGATIVE HBs Ab-NEGATIVE HBc Ab-NEGATIVE HAV Ab-POSITIVE [**2117-3-4**] 09:18PM   HCV Ab-POSITIVE* [**2117-3-4**] 09:18PM   WBC-11.9* RBC-4.06* HGB-11.2* HCT-33.5* MCV-83 MCH-27.7 MCHC-33.5 RDW-14.8 [**2117-3-4**] 09:18PM   NEUTS-69.4 LYMPHS-22.2 MONOS-5.4 EOS-2.3 BASOS-0.7 [**2117-3-4**] 09:18PM   PLT COUNT-647* [**2117-3-4**] 09:18PM   PT-12.9 PTT-23.6 INR(PT)-1.1  on dishcarge from the [**Hospital1 **], pt.s platelet count was 1,049,000.
This is felt to be a reactive thrombocytosis due to the combined effects of: multiple recent surgeries, and also possibly post alcohol abuse thrombocytopenia recovery.
Here thre were no stigmata or symptoms of thrombotic complication of this thrombocytosis (uncommon in reactive thrombocytosis) and aspirin 325 mg was started for combined effect of platelet inhibition and secondary prevention given known cad and nstemi suffered at outside hospital prior to admission here.
ERCP Report   major papilla s/p sphincterotomy, PD stent in place PD stent (later removed)  CCY clips Dilated PD Distal CBD  No cystic duct leak Balloon sweep Date: Friday, [**2117-3-5**] Endoscopist(s): [**Name6 (MD) **] [**Name8 (MD) 19087**], MD (attending) [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], MD (fellow)  Patient: [**Known firstname **] [**Last Name (NamePattern1) 86101**]  Ref.Phys.
The patient was administered MAC anesthesia.
The procedure was not difficult.
The patient tolerated the procedure well.
Findings: Esophagus: Limited exam of the esophagus was normal Stomach: Limited exam of the stomach was normal Duodenum: Limited exam of the duodenum was normal Major Papilla: Normal major papilla Cannulation:  Cannulation of the pancreatic duct was performed with a sphincterotome after a guidewire was placed in order to place a PD stent to facilitate biliary cannulation.
Cannulation of the biliary duct was performed with a sphincterotome after a guidewire was placed.
A sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire.
A 4cm by 5FR pancreatic stent was placed successfully to aid in biliary cannulation.
The plastic pancreatic duct stent was removed successfully with a snare.
Cannulation of the pancreatic duct was performed with a sphincterotome after a guidewire was placed in order to place a PD stent to facilitate biliary cannulation.
A 4cm by 5FR pancreatic stent was placed successfully to aid in biliary cannulation.
Cannulation of the biliary duct was performed with a sphincterotome after a guidewire was placed.
A sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire.
The plastic pancreatic duct stent was removed successfully with a snare.
NPO overnight with aggressive IV fluid hydration with LR at 200 cc/hr if he can tolerate the rate.
Additional notes: The procedure was performed by Dr. [**Last Name (STitle) **] and the GI fellow.
He tolerated resumption of a regular diet without difficulty once his ileus resolved with holding of large narcotic doses given in the ICU.
LE when pressors given at outside hospital, and, our CT here demonstrated thrombosis of his prior bypass grafts (likely old) - he maintained good perfusion of the Lt.
Treatment for bacteremia continued with meropenem, and course was completed on [**2117-3-9**].
He required some parenteral haldol for agitation while in the intensive care unit.
Was on heparin early this admit, now off.
After ERCP, aspirin was started - his aspirin allergy is GERD only, so a PPI was added for prophylaxis and protection.
Beta blockers were continued.
He should be considered for statin and ace inhibitor as an outpatient in follow up with a cardiologist.
Now s/p AKA as above.
- Post op followup as indicated in the discharge instructions.
Communication: Patient, wife [**Name (NI) **] [**Telephone/Fax (1) 86103**]  Medications on Admission: Medications at home: Atenolol 25 mg daily per notes (not clear that he was actually taking any) .
Medications at transfer: Ertapenem 1 gram daily Metoprolol 5 mg IV Q6H Protonix 40 mg daily Albuterol nebs Q2H prn Morphine 2-4 mg prn Haldol 4 mg Q8H prn agitation Heparin SC NS at 75 cc/hr   Discharge Medications: 1.
Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1) mL Injection TID (3 times a day).
Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Metoclopramide 10 mg Tablet Sig: One (1) Tablet PO Q 8H (Every 8 Hours) as needed for nausea.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Ipratropium Bromide 0.02 % Solution Sig: One (1) neb Inhalation Q6H (every 6 hours) as needed for sob/wheeze.
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Acetaminophen 500 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for pain: maximum of 2 grams per day.
Nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr Transdermal DAILY (Daily).
Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every 4-6 hours as needed for pain.
therapy completed, surveillance cultures no growth to date) s/p open ccy s/p rt LE BKA amputation Deconditioning HCV infection, chronic Ongoing polysubstance abuse and tobacco use (alcohol, cocaine)  Discharge Condition: Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - requires assistance or aid (walker or cane)  Discharge Instructions: See below  Followup Instructions: Primary MD: ([**Doctor First Name **] J.
